A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : Dpyr / deoxypyridinoline

[Related PubMed/MEDLINE]
Total Number of Papers: 211
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   Dpyr  (>> Co-occurring Abbreviation)
Long Form:   deoxypyridinoline
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Effects of the Hormone Replacement Therapy and of Soy Isoflavones on Bone Resorption in Postmenopause. BMD, HRT
2017 Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy. BGP, BMD, Cr, FPG, iPTH, OPG, PINP, PIO, Pyr, T2DN, TC, TG, VD
2017 Urinary levels of pyridinoline and deoxypyridinoline and bone mineral density in children with type 1 diabetes mellitus. ALP, BMD, DM, PTH, Pyr
2014 Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin. BMD
2014 Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus. QUS, T1DM
2013 Safety and efficacy of polycalcium for improving biomarkers of bone metabolism: a 4-week open-label clinical study. BALP, Ca, OSC
2013 [Experimental study on effect of anhydroicaritin phytosomes in preventing and treating bone loss and enhancing bone quality in ovariectomized osteoporosis rats]. AIP, ALP, b-Ca, BMD, Cr, s-P, sCa, U-Ca, U-P
2011 Dok-1 and Dok-2 deficiency induces osteopenia via activation of osteoclasts. BFR, MAR, MS/BS
2011 Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard. Gal-Pyr, GluGal-Pyr, Pyr
10  2010 Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization? BMC, BMD, Pyr
11  2009 [Inhibition of soy isoflavone intake on bone loss in menopausal women: evaluated by meta-analysis of randomized controlled trials]. BAP, RCTs, SBMD
12  2007 The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. BMD, EPO, OPG, RANKL
13  2006 Acute effects of a single session of aerobic exercise with or without weight-lifting on bone turnover in healthy young women. ALP, AVRM, CT, OC, PTH, WE
14  2006 Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. BMD, PD
15  2006 Ingestion of difructose anhydride III, a non-digestible disaccharide, improves postgastrectomy osteopenia in rats. DFAIII, FOS
16  2006 [Calcium and protein intake and bone markers in premenopausic and posmenopausic women with normal bone mineral density from Comodoro Rivadavia (Argentina)]. BAPh, BMD, Ca, CaI, CREA, PrI
17  2006 [Effect of jiangu granule on levels of urinary deoxypyridinoline and osseous intigrin beta1 mRNA expression in Ovariectomized osteoporosis model rats]. ITG beta1, JGG
18  2005 Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. BGP, BMD, PD, PTH, UPDRS-III
19  2005 Accelerated bone turnover in pregnant women with McCune-Albright syndrome. ALP, CT, Hpr, iOC, iPTH, PTHrP, Pyr
20  2005 Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial. AP, Pyr
21  2005 Clinical correlations of potential activity markers in systemic sclerosis. bET-1, IL-6, NPIIIP, Pyr, sICAM-1, sIL-2R, SSc, sVCAM-1, vWFAg
22  2005 Dietary soy protein and isoflavones: no effect on the reproductive tract and minimal positive effect on bone resorption in the intact female Fischer 344 rat. BMD, IF, SD
23  2005 Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis. ALP, OC, OC, OC
24  2005 One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. JSW, OA, Pyr, WOMAC
25  2005 The relationship between the zinc nutritive status and biochemical markers of bone turnover in older European adults: the ZENITH study. Pyr
26  2004 Beneficial effect of etidronate therapy in immobilized hip fracture patients. ---
27  2004 Effects of phytoestrogens on bone turnover in postmenopausal women with a history of breast cancer. Pyr
28  2004 Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients. BALP, HD, IGF, IGFBP, PTH, Pyr, RDC
29  2004 Relationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women. A-dione
30  2004 The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia. BMD, HA, Pyr, sham
31  2004 The urinary excretion of pyridinoline and deoxypyridinoline during rheumatoid arthritis therapy with infliximab. PYD
32  2004 TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. anti-TNF-alpha Ab, BFR, BMD, CIA, OPG, RA
33  2004 Utility of urinary pyridinoline and deoxypyridinoline ratio for diagnosis of osteoarthritis at temporomandibular joint. HPLC, OA, Pyr, TMJ
34  2003 Assessment of bone metabolism in cadmium-induced renal tubular dysfunction by measurements of biochemical markers. bone-ALP, Cd, GFR, intact-BGP, PICP, Pyr, RTD
35  2003 Association between craniofacial growth and urinary bone metabolic markers (pyridinoline, deoxypyridinoline) in growing rats. Pyr
36  2003 Changes in bone turnover markers during 14-day 6 degrees head-down bed rest. ALP, OC
37  2003 Changes in urinary bone resorption markers (pyridinoline, deoxypyridinoline) resulting from experimentally-induced osteoarthritis in the temporomandibular joint of rats. OA, Pyr, TMJ, TMJ-OA
38  2003 Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis. BALP, BMD, IL-11, OC, PO, TGF-beta2
39  2003 Evaluation of serum biochemical markers of bone metabolism for early diagnosis of nonunion and infected nonunion fractures in rabbits. BSALP, OC
40  2003 Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. BALP, DEXA, LS-BMD, OC
41  2003 Search for new urinary biochemical markers of collagen degradation in man. CL, glc-gal-pyr, HPLC, Pyr
42  2003 Tail suspension induces bone loss in skeletally mature mice in the C57BL/6J strain but not in the C3H/HeJ strain. ALP, C3H
43  2003 Urinary excretion of deoxypyridinoline increases after gastrointestinal surgery. SIR
44  2003 Urinary excretion of pyridinium cross-links and serum osteocalcin levels in patients with primary high-grade osteosarcoma. AP, OC, Pyr, Ucr
45  2003 [Bone metabolism in adolescent girls with short course of anorexia nervosa]. AN, BGP, BMD, TAP
46  2003 [Changes in the articular compartment in advanced osteoarthritis]. BAP, BS, CA, CHON, OA, Pyr, SF, SM
47  2002 Biological variability of biochemical markers of bone turnover in healthy women. BAP, iPTH, Pyr, U-CTX
48  2002 Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. AI, ALP, BALP, BMD, CS, DEXA, Pyr
49  2002 Bone resorption versus estrogen loss following oophorectomy and menopause. BMD, Cr, ICTP, Pyr
50  2002 Does active treatment of rheumatoid arthritis limit disease-associated bone loss? DAS, DMARDs, Pyr, RA
51  2002 Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. B-ALP, BGP, BMD, HRT, Pyr
52  2002 Olpadronate prevents the bone loss induced by cyclosporine in the rat. BALP, BMD, OPD
53  2002 Osteoporosis and beta-thalassemia major: role of the IGF-I/IGFBP-III axis. IGFBP-III, IGFBP-III, Pyr
54  2002 Pregnancy and lactation affect markers of calcium and bone metabolism differently in adolescent and adult women with low calcium intakes. BAP, iPTH
55  2002 Relationship of bone turnover parameters, endogenous hormones and vit D deficiency to hip fracture in elderly postmenopausal women. iPTH, tALP and bALP
56  2002 Single infusion of neridronate (6-amino-1-hydroxyhexylidene-1,1-bisphosphonate) in patients with active rheumatoid arthritis: effects on disease activity and bone resorption markers. CRP, ESR, RA
57  2002 The efficacy of two dosages of a continuous combined hormone replacement regimen. HDL-C, HRT, LDL-C, NETA, TC, TG
58  2002 [Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism]. BALP, BMD, DXM
59  2001 Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. BMD
60  2001 Bone metabolism and body composition in Japanese patients with active acromegaly. BMD, OC
61  2001 Changes in bone turnover following gonadotropin-releasing hormone (GnRH) agonist administration and estrogen treatment in cynomolgus monkeys: a short-term model for evaluation of antiresorptive therapy. BMD, GnRH, GnRHa
62  2001 Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women. BMD, BMI, OC
63  2001 Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism. ALP, Ca
64  2001 Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism. ALP, BFR, iOC, MAR, O.Th, PICP, TRAP
65  2001 Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. BMD, PHPT, PTH
66  2001 Effects of short-term use of ibuprofen or acetaminophen on bone resorption in healthy men: a double-blind, placebo-controlled pilot study. NSAIDs
67  2001 Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micro-mass cultures. FTIR, Hcys, Pyr
68  2001 Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon. Pyr, stPyr
69  2001 Intravenous 1alpha, 25[OH]2 vitamin D3 (calcitriol) pulse therapy for bone lesions in a murine model of chronic cadmium toxicosis. PTH
70  2001 No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status. Cr, Pyr, RVAU
71  2001 Osteoporosis in men: a potential role for the sex hormone binding globulin. BMD, BMI, BSAP, CI, SHBG
72  2001 Serum bone sialoprotein: a marker of bone resorption in postmenopausal osteoporosis. BSP, DEXA, LS-BMD, Pyr
73  2001 Serum bone specific alkaline phosphatase and urinary deoxypyridinoline in postmenopausal osteoporosis. BMD, BSALP, HRT, tALP
74  2001 The effect of calcium intake on bone composition and bone resorption in the young growing rat. Pyr
75  2001 [Can sleep urine calcium concentration corrected by osmolality as a screening test identify subjects with risk to develop osteoporosis?]. Ca, Cr, Osm, Pyr
76  2000 Activity of rheumatoid arthritis and urinary pyridinoline and deoxypyridinoline. BMD, CRP, Pyr, RA
77  2000 Biochemical markers and bone mineral density in patients with hip fractures in men. BMD, DHEAS, LH, Pyr, Te
78  2000 Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myeloma. BAP, IL-6, Pyr, TGF, TNF
79  2000 Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. BAP, BMD, DHEA, PTH, RR, SHBG
80  2000 Bone mineral density and bone turnover in patients with knee osteoarthritis compared with generalized osteoarthritis. BMD, GOA, KOA, Pyr
81  2000 Calcitonin receptor mRNA in mononuclear leucocytes from postmenopausal women: decrease during osteoporosis and link to bone markers with specific isoform involvement. CTR, OsteoP, Pre-M, sBAP
82  2000 Changes in calcium, PTH and 1,25(OH)2 vitamin D3 during tail-suspension in ovariectomized rats: effects of estrogen administration. PTH
83  2000 Changes in levels of biochemical markers and ultrasound indices of Os calcis across the menopausal transition. iOC, Pyr
84  2000 Direct detection of crosslinks of collagen and elastin in the hydrolysates of human yellow ligament using single-column high performance liquid chromatography. DES, PEN, Pyr
85  2000 Effects of short-term administration of growth hormone in healthy young men, women, and women taking oral contraceptives. GH, IGF-1, LDL, OCs, SHBG
86  2000 Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women. Pyr, SHBG
87  2000 Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone. 11beta-HSD, Pyr, RT-PCR
88  2000 Isometric progressive resistive exercise for osteoporosis. ALP
89  2000 Milk basic protein: a novel protective function of milk against osteoporosis. BMD, MBP, sham
90  2000 Serum estradiol and sex hormone-binding globulin and the risk of hip fracture in elderly women: the EPIDOS study. RH, SHBG
91  2000 Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. BSAP, OC
92  2000 Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase-inhibitor. AA, MMP, Pyr
93  2000 The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia. BMC, BMD, DXA, ND, Pyr
94  2000 The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine. OC, PICP, Pyr
95  1999 Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group. BMD, BSAP, N-MID OC
96  1999 Biochemical markers of bone metabolism in mild ankylosing spondylitis and their relationship with bone mineral density and vertebral fractures. AS, BMD, PTH, Pyr
97  1999 Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: the Taiji study. ALP, BGP, BMD, Ca, Pyr
98  1999 Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. BALP, OC, Pyr
99  1999 Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. BALP, CT, Pyr
100  1999 Biochemical markers of bone turnover during hormone replacement therapy. HRT, OC, Pyr